1. indications for therapeutic anticoagulation 2. absolute contraindication to anticoagulation including: 1. active bleeding, 2. recent (within 1 month) history of bleed, 3. dual (but not single) antiplatelet therapy, 4. active gastrointestinal and intracranial cancer, 5. a history of bronchiectasis or pulmonary cavitation, 6. hepatic failure with a baseline inr \> 1.5, 7. crcl \< 15ml/min, 8. a platelet count \< 25,000, 9. a history of heparin-induced thrombocytopenia (hit) within the past 100 days or in the presence of circulating antibodies, 10. contraindications to enoxaparin including a hypersensitivity to enoxaparin sodium, hypersensitivity to heparin or pork products, hypersensitivity to benzyl alcohol, 11. pregnant female, 12. inability to give or designate to give informed consent, 13. participation in another blinded trial of investigational drug therapy for covid-19

1. indications for therapeutic anticoagulation 2. absolute contraindication to anticoagulation including: 1. active bleeding, 2. recent (within 1 month) history of bleed, 3. dual (but not single) antiplatelet therapy, 4. active gastrointestinal and intracranial cancer, 5. a history of bronchiectasis or pulmonary cavitation, 6. hepatic failure with a baseline inr \> 1.5, 7. crcl \< 15ml/min, 8. a platelet count \< 25,000, 9. a history of heparin-induced thrombocytopenia (hit) within the past 100 days or in the presence of circulating antibodies, 10. contraindications to enoxaparin including a hypersensitivity to enoxaparin sodium, hypersensitivity to heparin or pork products, hypersensitivity to benzyl alcohol, 11. pregnant female, 12. inability to give or designate to give informed consent, 13. participation in another blinded trial of investigational drug therapy for covid-19

indications for therapeutic anticoagulation absolute contraindication to anticoagulation including: active bleeding, recent (within 1 month) history of bleed, dual (but not single) antiplatelet therapy, active gastrointestinal and intracranial cancer, a history of bronchiectasis or pulmonary cavitation, hepatic failure with a baseline inr > 1.5, crcl < 15ml/min, a platelet count < 25,000, a history of heparin-induced thrombocytopenia (hit) within the past 100 days or in the presence of circulating antibodies, contraindications to enoxaparin including a hypersensitivity to enoxaparin sodium, hypersensitivity to heparin or pork products, hypersensitivity to benzyl alcohol, pregnant female, inability to give or designate to give informed consent, participation in another blinded trial of investigational drug therapy for covid-19

indications for therapeutic anticoagulation absolute contraindication to anticoagulation including: active bleeding, recent (within 1 month) history of bleed, dual (but not single) antiplatelet therapy, active gastrointestinal and intracranial cancer, a history of bronchiectasis or pulmonary cavitation, hepatic failure with a baseline inr > 1.5, crcl < 15ml/min, a platelet count < 25,000, a history of heparin-induced thrombocytopenia (hit) within the past 100 days or in the presence of circulating antibodies, contraindications to enoxaparin including a hypersensitivity to enoxaparin sodium, hypersensitivity to heparin or pork products, hypersensitivity to benzyl alcohol, pregnant female, inability to give or designate to give informed consent, participation in another blinded trial of investigational drug therapy for covid-19

1. indications for therapeutic anticoagulation 2. absolute contraindication to anticoagulation including: 1. active bleeding, 2. recent (within 1 month) history of bleed, 3. dual (but not single) antiplatelet therapy, 4. active gastrointestinal and intracranial cancer, 5. a history of bronchiectasis or pulmonary cavitation, 6. hepatic failure with a baseline inr > 1.5, 7. crcl < 15ml/min, 8. a platelet count < 25,000, 9. a history of heparin-induced thrombocytopenia (hit) within the past 100 days or in the presence of circulating antibodies, 10. contraindications to enoxaparin including a hypersensitivity to enoxaparin sodium, hypersensitivity to heparin or pork products, hypersensitivity to benzyl alcohol, 11. pregnant female, 12. inability to give or designate to give informed consent, 13. participation in another blinded trial of investigational drug therapy for covid-19

1. indications for therapeutic anticoagulation 2. absolute contraindication to anticoagulation including: 1. active bleeding, 2. recent (within 1 month) history of bleed, 3. dual (but not single) antiplatelet therapy, 4. active gastrointestinal and intracranial cancer, 5. a history of bronchiectasis or pulmonary cavitation, 6. hepatic failure with a baseline inr > 1.5, 7. crcl < 15ml/min, 8. a platelet count < 25,000, 9. a history of heparin-induced thrombocytopenia (hit) within the past 100 days or in the presence of circulating antibodies, 10. contraindications to enoxaparin including a hypersensitivity to enoxaparin sodium, hypersensitivity to heparin or pork products, hypersensitivity to benzyl alcohol, 11. pregnant female, 12. inability to give or designate to give informed consent, 13. participation in another blinded trial of investigational drug therapy for covid-19